Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein A in children

Journal of Infectious Diseases

Volumn 183, Issue 6, 2001, Pages 887-896

  Simell, B ^a   Korkeila, M ^a   Pursiainen, H ^a   Kilpi, T M ^a   Kayhty H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; IMMUNOGLOBULIN A; PNEUMOLYSIN; PROTEIN A;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROIMMUNOASSAY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SALIVA; VACCINATION;

ACUTE DISEASE; ADHESINS, BACTERIAL; ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFANT; LIPOPROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; SALIVA; SECRETORY COMPONENT; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 0035869106     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319246     Document Type: Article

References (46)

1. The epidemiology of pneumococcal infection in children in the developing world
2. The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods
3. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective cohort study
4. Host defense against adhesion of bacteria to mucosal surfaces
5. Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication
6. Pneumococcal vaccine and acute otitis media
7. Prevention of otitls media in children by pneumococcal vaccination
8. Use of pneumococcal vaccine for prevention of recurrent otitis media in infants in Boston
9. Polysaccharide-protein conjugates: A new generation of vaccines
10. New vaccines for prevention of pneumococcal infections
11. Efficacy of heptavalent pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Impact on pneumonia, otitis media, and an update on invasive disease-results of the northern California Kaiser Permanente Efficacy Trial
12. Efficacy of a pneumococcal conjugate vaccine against acute otitis media
13. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid
14. Pneumococcal conjugate vaccination in toddlers: Mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies
15. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae
16. Molecular analysis of putative pneumococcal virulence proteins
17. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae
18. Analysis of a surface protein of Streptococcus pneumoniae recognized by protective monoclonal antibodies
19. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae
20. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae
21. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component
22. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
23. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia
24. Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin)
25. Molecular cloning, characterization and complete nucleotide sequence of the gene for pneumolysin, the sulfhudryl-activated toxin of Streptococcus pneumoniae
26. PspA, a surface protein of Streptococcus pneumoniae is capable of eliciting protection against pneumococci of more than one capsular serotype
27. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae
28. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae
29. Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae
30. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide
31. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
32. Protein secretion in bacilli
33. Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis
34. Bacillus subtilis and its relatives: Molecular, biological and industrial workhorses
35. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
36. Development of serum and salivary antibodies to pneumococcal protein antigens PspA, PsaA and Ply in children
37. Streptococci and aerococci
38. PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice
39. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
40. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines
41. Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract
42. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins
43. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis
44. Oral immunization with PspA elicits protective immunity against Streptococcus pneumoniae infection
45. Intranasal immunization with PspA can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae
46. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae